Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026)

Perspective Therapeutics' Non-Current Assets history runs 16 years deep, the most recent figure standing at $135.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 19.2% year-over-year to $135.4 million; the TTM figure through Mar 2026 stood at $485.1 million (up 11.21% YoY), while the FY2025 annual figure was $118.6 million, up 7.86% from the prior year.
• Non-Current Assets came in at $135.4 million for Q1 2026 at Perspective Therapeutics, up from $118.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $135.4 million in Q1 2026 to a low of $3.4 million in Q1 2022.
• A 5-year average of $80.9 million and a median of $90.1 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 2504.44% in 2023 and fell 3.85% in 2025, its largest moves.
• Perspective Therapeutics' Non-Current Assets stood at $4.9 million in 2022, then surged by 1562.31% to $81.1 million in 2023, then surged by 35.64% to $109.9 million in 2024, then rose by 7.86% to $118.6 million in 2025, then advanced by 14.2% to $135.4 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $135.4 million, $118.6 million, and $116.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison